CAR T-Cell Therapy is a breakthrough in cancer treatment, especially for patients with advanced-stage blood cancers such as leukemia and lymphoma. This innovative treatment harnesses the power of the immune system to fight cancer by genetically modifying the patient’s own T-cells. In this article, we will discuss the top hospitals in India that offer CAR T-Cell Therapy, the costs involved, and its success in treating late-stage cancers.
Medical disclaimer: This content is for general awareness and does not replace a doctor’s consultation. For diagnosis or treatment decisions, consult a qualified specialist.
Want a free hospital opinion and cost estimate?
Send your reports on WhatsApp or online. We check with accredited hospitals whether you may qualify and what the package would cost.
Chat on WhatsAppSend reports online
What is CAR T-Cell Therapy?
CAR T-Cell Therapy is an advanced form of immunotherapy that uses specially modified T-cells to target and destroy cancer cells. These T-cells are extracted from the patient, engineered in a lab to express chimeric antigen receptors (CARs), and then reintroduced into the body to attack cancer cells with precision.
How Does CAR T-Cell Therapy Work?
The process begins by collecting T-cells from the patient’s blood. These cells are then genetically modified in a laboratory to produce CARs, which allow them to recognize and bind to specific proteins on the surface of cancer cells. Once infused back into the patient, the CAR T-cells multiply and aggressively target cancer cells, often leading to tumor reduction or remission.
Eligibility for CAR T-Cell Therapy
Not every cancer patient is eligible for CAR T-Cell Therapy. It is currently approved for treating certain types of blood cancers like acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL), particularly in cases where other treatments have failed. In India, NexCAR19, developed by IIT Bombay, Tata Memorial Centre and ImmunoACT, was approved by the CDSCO in October 2023 for B-cell lymphoma and leukaemia (NCI). See our NexCAR19 guide for its cost, eligibility and where it is given. Eligibility depends on factors such as the patient’s overall health, cancer type, and stage.
Benefits of CAR T-Cell Therapy for Cancer Treatment
One of the key benefits of CAR T-Cell Therapy is its ability to offer hope to patients with cancers that have not responded to traditional treatments. This therapy is highly personalized and has produced responses in a majority of patients in some trials of refractory or relapsed blood cancers (figures below). Additionally, it offers a more targeted approach, potentially reducing damage to healthy tissues compared to chemotherapy or radiation.
Types of Cancer and Stages Treated with CAR T-Cell Therapy
CAR T-Cell Therapy is primarily used for treating hematologic cancers, including acute lymphoblastic leukemia (ALL), diffuse large B-cell lymphoma (DLBCL), and mantle cell lymphoma. It has been especially effective in advanced or late-stage cancers, where other treatment options may have failed. Ongoing research is exploring its use in other cancer types, such as multiple myeloma and solid tumors.
Top Hospitals Offering CAR T-Cell Therapy in India
India is quickly becoming a destination for advanced cancer treatments like CAR T-Cell Therapy, with several renowned hospitals offering this service. Leading hospitals include Tata Memorial Centre in Mumbai, where the NexCAR19 trials were run (NCI). Which other hospitals administer CAR T-Cell Therapy, and which product they use, changes quickly, so confirm availability and the product with the hospital before travelling.
Cost of CAR T-Cell Therapy in India
The cost of CAR T-Cell Therapy in India ranges from ₹34 lakh to ₹48 lakh, depending on the hospital, the complexity of the case, and any additional treatments required. While this might seem high, it is still considerably lower than in countries like the US or Europe, where an infusion costs about $400,000 (roughly ₹3.8 crore) according to the NCI.
About these prices: all-inclusive package estimates for international patients at accredited private hospitals, compiled in September 2026 from published hospital and facilitator price lists (about ₹96 per US dollar). Indian residents are usually quoted lower domestic tariffs; your final cost is confirmed after a specialist reviews your reports.
Success Rates of CAR T-Cell Therapy
CAR T-Cell Therapy results depend on the cancer, the CAR-T product and how much disease is present, so figures from one trial do not carry over to another product. In the ZUMA-1 trial, 101 patients with refractory large B-cell lymphoma received axicabtagene ciloleucel: 83% responded, 58% achieved a complete response and 42.6% were alive at five years[c1]. However, long-term outcomes vary depending on individual factors, and some patients may experience recurrence.
NexCAR19 and axicabtagene ciloleucel: what each trial reported
| Dimension | NexCAR19 (actalycabtagene autoleucel), India | Axicabtagene ciloleucel, ZUMA-1 trial |
|---|
| Approval | India (CDSCO), October 2023 | Approved in the US |
| Patients studied | 64 people with B-cell lymphoma or leukaemia in two Indian trials; 53 could be evaluated (38 lymphoma, 15 leukaemia) | 101 patients with refractory large B-cell lymphoma |
| Response | Responses in 68% of lymphoma and 72% of leukaemia patients; every leukaemia response was a complete response | 83% responded; 58% had a complete response |
| Five-year survival | No five-year figure in the sources cited here | 42.6% alive at five years |
| Side effects reported | Severe cytokine release syndrome in 5% of the 53; no neurological side effects reported in that group | Cytokine release syndrome and neurological events are known with CAR-T products approved in the US |
| Expected price | Around $50,000 (NCI); Indian hospital packages on this page run ₹34–48 lakh | Around $400,000 per infusion in the US (NCI) |
How to read this: the two columns come from different trials, patient groups and follow-up times, so this is not a head-to-head comparison. The NexCAR19 figures were presented at the American Society of Hematology meeting in December 2023 as reported by the NCI; the trials were small and were funded by ImmunoACT, the company that makes the product. ZUMA-1 figures are from the five-year follow-up cited in the references[c1].
CAR T-Cell Therapy vs. Traditional Cancer Treatments
Unlike chemotherapy and radiation, which target both cancerous and healthy cells, CAR T-Cell Therapy offers a more precise approach. The T-cells are engineered to recognise a marker on the cancer cells (CD19 for NexCAR19), but they also destroy normal B cells and can cause cytokine release syndrome and neurological effects, so treatment needs a specialised centre. Additionally, CAR T-Cell Therapy has been effective in treating cancers that have proven resistant to conventional treatments.
Factors Affecting the Cost of CAR T-Cell Therapy
The cost of CAR T-Cell Therapy can be influenced by several factors, including the hospital’s location, the patient’s overall health condition, and the need for additional treatments such as chemotherapy or radiation before or after CAR T-cell infusion. It's essential to consult with the hospital to get a detailed cost breakdown based on individual needs.
Is CAR T-Cell Therapy Safe?
While generally considered safe, CAR T-Cell Therapy is not without risks. The most common side effect is cytokine release syndrome (CRS), which can cause symptoms such as fever, low blood pressure, and difficulty breathing. Neurological side effects, such as confusion or seizures, have also been reported. However, these side effects are typically manageable with supportive care in a hospital setting.
How to Prepare for CAR T-Cell Therapy in India
Before undergoing CAR T-Cell Therapy, patients need to undergo a series of tests to ensure they are eligible for the treatment. This often includes blood tests, imaging scans, and consultations with oncologists. In some cases, patients may need to receive chemotherapy before the T-cells are harvested and modified. Preparation is crucial to maximize the effectiveness of the therapy and minimize potential risks.
Frequently Asked Questions (FAQs) About CAR T-Cell Therapy in India
What is the average cost of CAR T-Cell Therapy in India?
The cost of CAR T-Cell Therapy in India typically ranges from ₹34 lakh to ₹48 lakh, depending on the hospital and treatment specifics.
Which hospitals in India provide CAR T-Cell Therapy?
Tata Memorial Centre in Mumbai ran the NexCAR19 trials (NCI). Other hospitals offer or are setting up CAR T-Cell Therapy, but availability and the product used change quickly, so confirm with the hospital before travelling.
How long does the CAR T-Cell Therapy treatment take?
The entire process, from T-cell extraction to reinfusion, typically takes several weeks to months, depending on the complexity of the case.
Are there any side effects of CAR T-Cell Therapy?
Yes, common side effects include cytokine release syndrome (CRS), fever, and neurological symptoms, which are usually manageable with medical support.
Who is eligible for CAR T-Cell Therapy?
Patients with certain types of blood cancers, such as acute lymphoblastic leukemia and non-Hodgkin lymphoma, may be eligible if they have not responded to other treatments.
What types of cancer can CAR T-Cell Therapy treat?
It is primarily used for treating blood cancers, such as leukemia and lymphoma, but ongoing research is exploring its use in other cancers.
How effective is CAR T-Cell Therapy for late-stage cancer?
CAR T-Cell Therapy has produced remission in a substantial share of patients with refractory or relapsed blood cancers in trials, though not in all of them.
Can CAR T-Cell Therapy be combined with other treatments?
Yes, in some cases, CAR T-Cell Therapy may be combined with chemotherapy or radiation to enhance its effectiveness.
What is the recovery process like after CAR T-Cell Therapy?
Patients typically recover within a few weeks, although some may experience side effects that require ongoing monitoring and supportive care.
Is CAR T-Cell Therapy covered by insurance in India?
Coverage for CAR T-Cell Therapy varies by insurance provider. It is advisable to consult with your insurance company to determine if this treatment is covered under your policy.
CAR T-cell therapy cost in India: why it is among the most expensive cancer treatments, what the manufacturing process adds, and what a package covers. Car T-cell Therapy Cost in India